THE EFFECT OF DEGREE AND TYPE OF LEFT VENTRICULAR HYPERTROPHY ON VENTRICULAR ARRHYTHMIAS IN HYPERTENSION

Ivan S. Tasić, Dragan Djordjević, Svetlana Kostić

DOI Number
10.22190/FUMB170111004T
First page
027
Last page
031

Abstract


Finding the arrythmogenic potential in patients with arterial hypertension as well as its correlation with left ventricular hypertrophy (LVH), and its type and degree. The research included 109 hypertensive patients (pts) (54 male and 55 female), 54.2 ± 7.9 years old  without symptomatic coronary disease, myocardial infarction and  systolic dysfunction. All the pts had a clinical examination, ECG, 24 h Holter monitoring with Lown classification of ventricular arrhythmias, an echocardiogram with left ventricular mass index (LVMI) and a specific type of LVH. QT interval dispersion (QTd) was calculated on 12 leads standard ECG. 75 pts had LVH (LVMI: 172.6 ± 42.95 g/m2) while 35 pts were without LVH (109.3 ± 15.9 g/m2). Non sustained ventricular tachycardia was registered in 13 pts (17.6%) with LVH and 1 female patient without LVH (2.9%). Patients with VT had a considerably higher ILVM (214.9 ± 6.8 vs. 151.9 ± 47.2 g/m2) than the average and higher QTd (73.7 ± 19.1 vs. 55.2 ± 20.2). VT was registered in 3/19 (15.8%) with eccentric nedilated type LVH, 6/38 (15.8%) with concentric LVH, 1/11 (9.1) (disproportional septal LVH) and 3/5 ( 60%) with dilated LVH. Univariate analysis showed a considerable correlation between the degree of arrhythmias and ILVM (p<0.001) and QTd (p=0.012). Ventricular arrhythmias in patients with arterial hypertension are considerably correlated to the degree of LVH expressed in ILVM and QTd.


Keywords

hypertension, left ventricular hypertrophy, ventricular arrhythmia, QT

Full Text:

PDF

References


Mancia G, Giannattasio C, Turrini D, Grassi G, Omboni S. Structural cardiovascular alterations and blood pressure variability in human hypertension. J Hypertens Suppl 1995; 13(suppl 2):S7-S14.

Levy D, Garrison RJ, Savage DD, et al. Prognostic implications of echocardiographically-determined left ventricular mass in the Framingham Heart Study. N Engl J Med 1990; 322:1561-1566.

Kannel WB. Prevalence and natural history of electrocardiographic left ventricular hypertrophy. Am J Med 1983; 75(suppl 3A):4-11.

Almendral J, Villacastin PJ, Arenal A, Tercedor L, Merino LJ, Delcan LJ: Evidence favoring the hypothesis that ventricular arrhythmias have prognostic significance in left ventricular hypertrophy secondary to systemic hypertension. Am J Cardiol 1995; 76:60D-63D.

Surawicz B. Electrophysiologic substrate of torsade de pointes: dispersion of repolarization or early after depolarization. J Am Coll Cardiol 1989; 14:172184.

Bianco HT, Izar MC, Póvoa RM, et al. Left ventricular hypertrophy and QTc dispersion are predictors of long term mortality in subjects with type 2 diabetes. Int J Cardiol. 2014; 176(3):1170-1172.

Higham PD, Furniss SS, Campbell RWF. QT dispersion and components of the QT interval in ischemia and infarction. Br Heart J 1995; 73:3236.

Dahlof B, Devereux R, et al. The Losartan intervention for endpoint reduction (LIFE) in hypertension study. Rationale, design, and methods. Am J Hypertens 1997; 10:705-713.

Barr SG, Naas A, Freeman M, Lang CC, Struthers DA. QT dispersion and sudden unexpected death in chronic heart failure. Lancet 1994; 343:327-329.

Marwick TH, Gillebert TC, Aurigemma G, et al. Recommendations on the Use of Echocardiography in Adult Hypertension: A Report from the European Association of Cardiovascular Imaging (EACVI) and the American Society of Echocardiography (ASE). J Am Soc Echocardiogr 2015; 28(7):727-754.

Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I, Reichek N. Echocardiographic assessment of left ventricular hypertrophy: comparasion to necropsy findings. Am J Cardiol 1986; 57:450-458.

Savage DD, Garrison RJ, Kannel WB, Levy D, Anderson SJ, Strokes J III, Feinleib M, castilli WP. The spectrum of left ventricular hypertrophy in a general population sample: the Framingham Study. Circulation 1987; 75(suppl I):I-26-33.

Lown B, Wolf M: Approaches to sudden death from coronary heart disease. Circulation 1971; 44:130-142.

Casale PN, Devereux RB, Milner M. Value of echocardiographic measurement of left ventricular mass in predicting cardiovascular morbid events in hypertensive men. Ann Intern Med 1986; 105:173-178.

Levy D, Garrison RJ, Savage DD, et al. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 1990; 322:1561-1566.

Ghali JK, Kadakia S, Cooper RS, Liao YL. Impact of left ventricular hypertrophy on ventricular arrhythmias in the absence of coronary artery disease. J Am Coll Cardiol 1991; 17:1277-1282.

Szlachic J, Tubau JF, O'Kelly B. What is the role of silent coronary artery disease and left ventricular hypertrophy in the genesis of ventricular arrhythmias in men with essential hypertension? J Am Coll Cardiol 1992; 19:803-808.

Coste P, Clementy J, Besse P, Bricaud H. Left ventricular hypertrophy and ventricular dysrhythmic risk in hypertensive patients: evaluation by programmed electrical stimulation. J Hypertens 1988; 6: S116-118.

Cosin Aguilar J, Hernandez Martinez A, Andreas Conejos F. Mechanisms of ventricular arrhythmias in the presence of pathological hypertrophy. Eur Heart J 1993; 14(suppl J):65-70.

Ganau A, Devereux RB, Roman MJ, de Simone G, Pickering TG, Saba PS, et al. patterns of left ventricular hypertrophy and geometric remodeling in essential hypertension. J Am Coll Cardiol 1992; 19:1550-1558.

Phan D, Aro AL, Reinier K, Teodorescu C, Uy-Evanado A, Gunson K, Jui J, Chugh SS. Left ventricular geometry and risk of sudden cardiac arrest in patients with severely reduced ejection fraction. J Am Heart Assoc 2016 Aug 18; 5(8).

Ticleman RG, Crijus HJ, Wiesfeld AC, Posma J, Hamer HP, Lie KI. Increased dispersion of refractoriness in the absence of QT prolongation in patients with mitral valve prolapse and ventricular arrhythmias. Br Heart J 1995; 73:37-40.

Glancy JM, Garratt CJ, Woods KL, de Bono DP. QT dispersion and mortality after myocardial infarction. Lancet 1995; 345:

-948.

Day CP, McComb JM, Campbel RW. QT dispersion: an indication of arrhythmia risk in patients with long QT intervals. Br Heart J 1990; 63:342-344.

de Bruyne MC, Hoes AW, Kors JA, Hofman A, van Bemmel JH, Grobbee DE: QTc Dispersion predicts cardiac mortality in the elderly; The Rotterdam Study: Circulation 1998; 97:467-472.

Schouten VJA, Vliegen HW, van der Laarse A, Huysmans HA. Altered calcium handling at normal contractility in hypertrophied rat heart. J Mol Cell Cardiol 1990; 22(9):987-988.

Fu GS, Meissner A, Simon R. Repolarization dispersion and sudden cardiac death in patients with impaired left ventricular function. Eur Heart J 1997; 18:281-289.




DOI: https://doi.org/10.22190/FUMB170111004T

Refbacks

  • There are currently no refbacks.


ISSN 0354-2017 (Print)

ISSN 2406-0526  (Online)